Diabetes Reversal Online Program and Study (DROP Study)
- Conditions
- Type 2 Diabetes
- Interventions
- Behavioral: plant-based diet
- Registration Number
- NCT05572502
- Lead Sponsor
- Physicians Committee for Responsible Medicine
- Brief Summary
This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Data will also be analyzed to see if participation in the program results in reductions glycated hemoglobin levels, body weight, and cholesterol levels.
- Detailed Description
This study aims to assess the feasibility and implementation of an online, plant-based, diabetes reversal program in a community setting. The study will also assess changes in glycated hemoglobin, body weight, and plasma lipids with an online 12-week, plant-based, nutrition education program. These health benefits may illustrate feasibility to physicians and healthcare professionals elsewhere, in addition to their value for the individual research participants.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
- U.S. Men and women meeting the age of majority, defined as follows: Age 19 or older in Nebraska and Alabama; Age 21 or older in Mississippi; Age 18 or older in all other states
- Prior diagnosis of type 2 diabetes mellitus
- Use of recreational drugs in the past 6 months
- Pregnancy or intention to become pregnant during the study period, as verified by self-report
- Unstable medical or psychiatric illness
- Lack of English fluency
- Inability to maintain current medication regimen
- Inability or unwillingness to participate in all components of the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Vegan diet plant-based diet All participants will follow a low-fat vegan diet. There are no other study arms or control group.
- Primary Outcome Measures
Name Time Method Glycated hemoglobin 12 weeks A1c will be measured before and after the study period
- Secondary Outcome Measures
Name Time Method body weight 12 weeks participants will track body weight weekly using a RNFO scale
total cholesterol 12 weeks total cholesterol will be measured before and after the study period
LDL cholesterol 12 weeks LDL cholesterol will be measured before and after the study period
medication usage 12 weeks changes in medications to treat diabetes will be tracked during the study period
Trial Locations
- Locations (1)
Physician Committee for Responsible Medicine
🇺🇸Washington, District of Columbia, United States